Granted Patent
B2
US 12,280,073 · App. 18/222,690 · Granted Apr 22, 2025
Bi-functional co-polymer use for ophthalmic and other topical and local applications
Inventors:
Eugene Rex Cooper (Berwyn, PA); David Maxwell Kleinman (Rochester, NY); Andrew Loxley (Philadelphia, PA); Mark A. Mitchnick (East Hampton, NY)
Assignee:
Calm Water Therapeutics LLC
A61K31/785A61K9/0019A61K9/0043A61K9/0048A61K9/0051A61K9/0073A61K9/5031A61K9/5146A61K31/045A61K31/7036A61K31/74A61K31/765A61K35/02A61K45/06A61K47/34G02C7/04
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention contemplates a copolymer which is a graft or block copolymer useful to change wettability and surface characteristics of biological surfaces. Methods for use of these formulations and coatings to change wettability and sterically stabilize, and lubricate biological surfaces in a subject, for example, in the treatment of dry eye syndrome, and to prevent adherence of unwanted proteins, for example in the treatment of contact lens intolerance, are provided.
Claims (17)
1. A method of treating an ophthalmic disease or condition in a subject, comprising topically administering to an ocular surface of said subject a composition comprising a graft copolymer comprising:
(i) a positively charged backbone, wherein the positively charged backbone is
selected from the group consisting of poly(2-vinyl pyridine), poly(4-vinyl pyridine) and vinyl co-polymers thereof, and
(ii) one or more hydrophilic water soluble side chains selected from the group consisting of polyethylene glycols, polysaccharides, poly(meth)acrylates, polyacrylamides, polyvinyl alcohol (PVA), polyethyloxazoline, poly-N-vinyl pyrrolidone (NVP) and poly boronic-based polymers;
in an amount and for a duration so as to prolong the stability of the tear film of said subject.
2. A method of treating an ophthalmic disease or condition in a subject, comprising topically administering to an ocular surface of said subject a composition comprising a graft copolymer comprising:
(i) a positively charged backbone, wherein the positively charged backbone is chitosan, and
(ii) one or more hydrophilic water soluble side chains selected from the group consisting of polyethylene glycols, polysaccharides, poly(meth)acrylates, polyacrylamides, polyvinyl alcohol (PVA), polyethyloxazoline, poly-N-vinyl pyrrolidone (NVP) and poly boronic-based polymers;
in an amount and for a duration so as to prolong the stability of the tear film of said subject.
3. A method of treating an ophthalmic disease or condition in a subject, comprising topically administering to an ocular surface of said subject a composition comprising a graft copolymer comprising:
(i) a positively charged backbone, wherein the positively charged backbone is selected from the group consisting of poly(aminoethyl methacrylate) homo- and co-polymers containing N,N dimethylaminoethylmethacrylate repeat units, poly(trimethylammonioethyl methacrylate chloride), poly-(2-(dimethylamino) ethyl methacrylate) (pDMAEMA), poly-(2-(dimethylamino) ethyl methacrylateco-methacrylic acid) (pDMAEMA-co-MAA) and poly-(2-methyl-acrylic acid 2-[(2-dimethylamino-ethyl)-methylamino]-ethyl ester) (pDAMA), and cation guar gum, and
(ii) one or more hydrophilic water soluble side chains selected from the group consisting of polyethylene glycols, polysaccharides, poly(meth)acrylates, polyacrylamides, polyvinyl alcohol (PVA), polyethyloxazoline, poly-N-vinyl pyrrolidone (NVP) and poly boronic-based polymers;
in an amount and for a duration so as to prolong the stability of the tear film of said subject.
4. A method of treating an ophthalmic disease or condition in a subject, comprising topically administering to an ocular surface of said subject a composition comprising a graft copolymer comprising:
(i) a positively charged backbone, wherein the positively charged backbone is a positively charged PLL backbone, and
(ii) one or more hydrophilic water soluble side chains selected from the group consisting of polyethylene glycols, polysaccharides, poly(meth)acrylates, polyacrylamides, polyvinyl alcohol (PVA), polyethyloxazoline, poly-N-vinyl pyrrolidone (NVP) and poly boronic-based polymers;
in an amount and for a duration so as to prolong the stability of the tear film of said subject.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 7, 2025
From: COOPER, EUGENE REX; KLEINMAN, DAVID MAXWELL; LOXLEY, ANDREW; MITCHNICK, MARK A.
To: CALM WATER THERAPEUTICS LLC
Reel/Frame 069772/0297 →
Continuity (9)
Provisional Application
61153416
· Feb 18, 2009
References Cited (123)
US 5232984A
· Hubbell et al.
· 1993
[cited by applicant]
US 5380536A
· Hubbell et al.
· 1995
[cited by applicant]
US 5462990A
· Hubbell et al.
· 1995
[cited by applicant]
US 5518187A
· Bruno et al.
· 1996
[cited by applicant]
US 5567440A
· Hubbell et al.
· 1996
[cited by applicant]
US 5578442A
· Desai
· 1996
[cited by examiner]
US 5607698A
· Martin et al.
· 1997
[cited by applicant]
US 5627233A
· Hubbell et al.
· 1997
[cited by applicant]
US 5662883A
· Bagchi et al.
· 1997
[cited by applicant]
US 5665331A
· Bagchi et al.
· 1997
[cited by applicant]
US 5718388A
· Czekai et al.
· 1998
[cited by applicant]
US 5820882A
· Hubbell et al.
· 1998
[cited by applicant]
US 5849839A
· Hubbell et al.
· 1998
[cited by applicant]
US 5862999A
· Czekai et al.
· 1999
[cited by applicant]
US 6037328A
· Hu et al.
· 2000
[cited by applicant]
US 6231892B1
· Hubbell et al.
· 2001
[cited by applicant]
US 6350527B1
· Hubbell et al.
· 2002
[cited by applicant]
US 6596267B1
· Hubbell et al.
· 2003
[cited by applicant]
US 6652902B2
· Hubbell et al.
· 2003
[cited by applicant]
US 6732521B2
· Otake
· 2004
[cited by applicant]
US 6743521B2
· Hubbell et al.
· 2004
[cited by applicant]
US 6958148B1
· Green et al.
· 2005
[cited by applicant]
US 7029688B2
· Hubbell
· 2006
[cited by examiner]
US 7316845B2
· Hubbell
· 2008
[cited by examiner]
US 8802075B2
· Cooper
· 2014
[cited by examiner]
US 9005596B2
· Cooper
· 2015
[cited by examiner]
US 9283248B2
· Cooper
· 2016
[cited by examiner]
US 9884074B2
· Cooper
· 2018
[cited by examiner]
US 20020114778A1
· Xia et al.
· 2002
[cited by applicant]
US 20050202097A1
· Maskin
· 2005
[cited by applicant]
US 20060052340A1
· Tsuzuki
· 2006
[cited by examiner]
US 20060083781A1
· Shastri et al.
· 2006
[cited by applicant]
US 20060094643A1
· Svirkin et al.
· 2006
[cited by applicant]
US 20070203039A1
· Borazjani
· 2007
[cited by examiner]
US 20090264538A1
· Hubbell et al.
· 2009
[cited by applicant]
AU 683312B2
· 1997
[cited by applicant]
AU 761903B2
· 2003
[cited by applicant]
CA 2173317A1
· 1995
[cited by applicant]
CA 2286590C
· 2005
[cited by applicant]
CA 2341519C
· 2007
[cited by applicant]
CN 1644215A
· 2005
[cited by applicant]
EP 0553195B1
· 1997
[cited by applicant]
EP 0722470B1
· 2000
[cited by applicant]
EP 1009451B1
· 2003
[cited by applicant]
EP 1107802B1
· 2004
[cited by applicant]
GB 533195A
· 1941
[cited by applicant]
GB 722470A
· 1955
[cited by applicant]
GB 1009451A
· 1965
[cited by applicant]
GB 1107802A
· 1968
[cited by applicant]
WO 199847948A1
· 1998
[cited by applicant]
WO 199910022A2
· 1999
[cited by applicant]
WO 2004004744A1
· 2004
[cited by applicant]
WO 2006039467A2
· 2006
[cited by applicant]
WO 2006083781A1
· 2006
[cited by applicant]
WO 2008137066A1
· 2008
[cited by applicant]
WO 2009084069A2
· 2009
[cited by applicant]
WO 2010096558A1
· 2010
[cited by applicant]
Michael J. Doughty, Re-wetting, Comfort, Lubricant and Moisturizing Solutions for the Contact Lens Wearer, 22 Cont. Lens Ant. Eye, 116 (Year: 1999).
[cited by examiner]
Neeraj Kumar, et al, Polyanhydrides: An Overview, 54 Adv. Drug Del. Rev. 889 (Year: 2500).
[cited by examiner]
Shwu-Jen Chang, et al, Evaluation of Chitosan-g-PEG Copolymer for Cell Anti-Adhesion Application, 27 J Med. Bio. Eng. 41 (Year: 2007).
[cited by examiner]
[No Author Listed] “Aqueous Lubrication Inspired by Natural Mechanisms!” SuSoS AG, 1 page, Oct. 9, 2012 http://content. media.cebitde.media/000095/0095798eng.pdf.
[cited by applicant]
Burger, A. Isosterism and Bioisosterism in Drug Design, in Progress in Drug Research 37: 287-328 (Ernst Jucker, ed., Birkhauser Verlag, 1991), Abstract only.
[cited by applicant]
Baumeler, S. “Sugar Adsorption on PLL-g-PEG-coated Nb2O5 Surfaces,” ETH Zurich Laboratory for Surface Science and Technology, pp. 1-30, Jun. 2004.
[cited by applicant]
Benelli, U.“Systane® Lubricant Eye Drops In The Management Of Ocular Dryness,” Clinical Ophthalmology, vol. 5, pp. 783-790, Jun. 2011.
[cited by applicant]
Billinger, M., et al., “Polymer stent Coating For Prevention Of Neointimal Hyperplasia,” Original Contributions, 2006, Abstract, 6 pages.
[cited by applicant]
Binkert, A., et al., “Covalent Immobilization of PLL-g-PEG onto Silicone Hydrogel Contact Lenses,” AB Idealeague, 1 page, 2006.
[cited by applicant]
Blattler, T., et al., “High Salt Stability and Protein Resistance of Poly(1-lysine)-g-poly(ethylene glycol) Copolymers Covalently Immobilized via Aldehyde Plasma Polymer Interlayers on Inorganic and Polymeric Substrates…
[cited by applicant]
Bron, A., “Diagnosis of Dry Eye,” Survey of Ophthalmology, vol. 45, Supplement 2, pp. S221-S226, Mar. 2001.
[cited by applicant]
Chang J.C., et al., “Evaluation of Chitosan-g-PEG Copolymer for Cell Anti-Adhesion Application, Journal of Medical and Biological Engineering,” 27(1): 41-46, 2007.
[cited by applicant]
Doughty, M., “Re-Wetting, Comfort, Lubricant And Moisturising Solutions For The Contact Lens Wearer,” Contact Lens and Anterior Eye, vol. 22, Issue 4, pp. 116-126, 1999.
[cited by applicant]
Drobek, T, et al., “Nanotribology Of Surface-Grafted PEG Layers In An Aqueous Environment,” ETH Zurich, Laboratory for Surface Science Technology, Department of Materials, Langmuir pp. A-E, Sep. 5, 2007.
[cited by applicant]
Elbert, D., et al., “Self-Assembly And Steric Stabilization At Heterogeneous, Biological Surfaces Using Adsorbing Block Copolymers,” Chemistry & Biology, vol. 5, Issue 3, pp. 177-183, Mar. 1998.
[cited by applicant]
Fink, J., et al., “Comparative Study And Improvement Of Current Cell Micro-Patterning,” Lab Chip, vol. 7, pp. 672-670, Apr. 2007.
[cited by applicant]
Geerling, G., et.al., “The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction.” Invest Ophthalmol Vis Sci. 2011; 52(4): 2050-2064.
[cited by applicant]
Gensheimer, D., et al. “Novel Formulation Of Glycerin 1% Artificial Tears Extends Tear Film Break-Up Time Compared With Systane Lubricant Eye Drops,” Journal of Ocular Pharmacology, vol. 28, No. 5, Oct. 28, 2012.
[cited by applicant]
Germanier, Y., et al. “Enhanced Bone Apposition Around Biofunctionalized Sandblasted And Acid-Etched Titanium Implant Surfaces. A Histomorphometric Study In Miniature Pigs,” Clinical Oral Implants Research, vol. 17. No.…
[cited by applicant]
Gonzalez-Lopez, J., et al., “Self-associative behavior and drug-solubilizing ability of poloxamine (tetronic) block copolymers,” Langmuir, vol. 24, No. 19, pp. 10688-10697, Oct. 7, 2008.
[cited by applicant]
Haque, T., et al., “Superior Cell Delivery Features of Poly(ethylene glycol) Incorporated Alginate, Chitosan, and Poly-1-lysine Microcapsules,” Molecular Pharmaceutics, vol. 2, No. 1, pp. 29-36, 2005.
[cited by applicant]
Harris, L.G., et al., “
[cited by applicant]
Hansson, K, et al., “Whole blood coagulation on protein adsorption-resistant PEG and peptide functionalised PEG-coated titanium surfaces,” Biomaterials, vol. 26, Nov. 8, pp. 861-872, Mar. 2005.
[cited by applicant]
Huang, N.P., et al., “Poly(L-lysine)-g-poly(ethylene glycol) Layers on Metal Oxide Surfaces: Surface-Analytical Characterization and Resistance to Serum and Fibrinogen Adsorption,” Laboratory for Surface Science and Tec…
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US 10/24585, mailed Jun. 3, 2010 (9 pages).
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2016/041079, mailed Apr. 13, 2017 (10 pages).
[cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/US2016/041079, mailed Apr. 13, 2017 (7 pages).
[cited by applicant]
Kamao, T., et al., “Screening for dry eye with newly developed ocular surface thermographer.” Am. J. Ophthalmol., 2011, vol. 151, No. 5, pp. 782-791.
[cited by applicant]
Kumar, N., et al., “Polyanhydrides: An Overview,” Advance Drug Delivery Reviews, vol. 54, No. 7, pp. 889-910, Oct. 16, 2002.
[cited by applicant]
Kurrat, R., “Adsorption Of Biomolecules On Titanium Oxide Layers In Biological Model Solutions,” Swiss Federal Institute of Technology Zurich, Dissertation ETH Nr. 12891, 103 pages, 1998.
[cited by applicant]
Lee, S., et al., “Adsorption And Lubricating Properties Of Poly(L-Lysine)-Graft-Poly(Ethylene Glycol) On Human-Hair Surfaces,” ACS Applied Materials & Interfaces, vol. 1, No. 9, pp. 1938-1945, Sep. 2009.
[cited by applicant]
Lee, S., et al. “An Aqueous-Based Surface Modification Of Poly(Dimethylsiloxane) With Poly(Ethylene Glycol) To Prevent Biofouling,” Langmuir, vol. 21, No. 25, pp. 11957-11962, Dec. 6, 2005.
[cited by applicant]
Lemp, M., et al., “The Definition And Classification Of Dry Eye Disease: Guidelines from the International Dry Eye WorkShop,” The Ocular Surface, vol. 5, No. 2, 6 pages, Apr. 2007.
[cited by applicant]
Li, S., et al., “Pharmacokinetics and Biodistribution of Nanoparticles,” Molecular Pharmaceutics, vol. 5, No. 4, pp. 496-504, 2008.
[cited by applicant]
Maddikeri, R., et al., “Bacterial Adhesion to PLL-g-PEG Modified Surfaces,” European Cells and Materials, vol. 13, Supplement 2, pp. 70-71, 2007.
[cited by applicant]
Maddikeri R., et al., “Reduced Medical Infection Related Bacterial Strains Adhesion On Bioactive RGD Modified Titanium Surfaces: A First Step Toward Cell Selective Surfaces,” Wiley InterScience, Journal of Biomedical Ma…
[cited by applicant]
Marie, R., et al., “Use of PLL-g-PEG In Micro-Fluidic Devices For Localizing Selective and Specific Protein Binding,” Langmuir, vol. 22, No. 24, pp. 10103-10108, Nov. 21, 2006.
[cited by applicant]
Morgenthaler, S., et al., “Poly(L-Lysine)-Grafted-Poly(Ethylene Glycol)-Based Surface-Chemical Gradients. Preparation, Characterization, And First Applications,” Biointerphases, vol. 1, No. 4, pp. 156-165, Dec. 2006.
[cited by applicant]
Nalam, P., et al., “Macrotribological Studies of Poly(L-lysine)-graft-Poly(ethylene glycol) in Aqueous Glycerol Mixtures,” Tribology Letters, vol. 37, Issue 3, pp. 541-552, Mar. 2010.
[cited by applicant]
Nicolson, P., et al., “Soft Contact Lens Polymers: An Evolution,” Biomaterials, Ophthalmic Special Edition, vol. 22, Issue 24, pp. 3273-3283, Dec. 15, 2001.
[cited by applicant]
Ousler, G., et al., “An Evaluation of Tear Film Break up Time extension and Ocular Protection Index Scores Among Three Marketed Lubricant Eye Drops,” Cornea, vol. 26, No. 8, pp. 949-952, Sep. 2007.
[cited by applicant]
Pasche, S., et al., “Compression Of Adsorbed Poly(L-Lysine)-G-Poly(Ethylene Glycol) Measured By AFM,” European Cells and Materials, vol. 6, Supplement 1, p. 44, 2003.
[cited by applicant]
Pasche, S., et al., “Poly(L-lysine)-graft-poly(ethylene glycol) Assembled Monolayers on Niobium Oxide Surfaces: A Quantitative Study of the Influence of Polymer Interfacial Architecture on Resistance to Protein Adsorpti…
[cited by applicant]
Patani, G., et al., “Bioisosterism: A Rational Approach in Drug Design,” Chemical Reviews, vol. 96, No. 8, pp. 3147-3176, Dec. 19, 1996.
[cited by applicant]
Rossetti, F., et al. “Interaction of poly(L-lysine)-g-poly(ethylene glycol) with supported phospholipid bilayers,” Biophysical Journal, vol. 87, No. 3, pp. 1711-1721, Sep. 2004.
[cited by applicant]
Ruiz-Taylor, L.A., et al., “Monolayers of derivatized poly(1-lysine)-grafted poly(ethylene glycol) on metal oxides as a class of biomolecular interfaces,” Proceedings of the National Academy of Sciences of the United St…
[cited by applicant]
Sato, A., et al., “Polymer Brush-Stabilized Polyplex For A siRNA Carrier With Long Circulatory Half-Life,” Journal of Controlled Release, vol. 122, No. 3, pp. 209-216, Oct. 8, 2007.
[cited by applicant]
Sawhney, A., et al., “Poly(ethylene oxide)-graft-poly(L-lysine) copolymers to enhance the biocompatibility of poly(L-lysine)-alginate microcapsule membranes,” Biomaterials, vol. 12, Issue 12, pp. 863-870, 1992.
[cited by applicant]
Schuler, M., et al., “Biomimetic Modification Of Titanium Dental Implant Model Surfaces Using The RGDSP-Peptide Sequence: A Cell Morphology Study,” Biomaterials, vol. 27, No. 21, pp. 4003-4015, 2006.
[cited by applicant]
Simmons, P., et al., “Clinical Performance Of A Mid-Viscosity Artificial Tear For Dry Eye Treatment,” Cornea, vol. 26, No. 3, pp. 294-302, Apr. 2007.
[cited by applicant]
Supplementary European Search Report for European Application No. EP 10744296, dated Nov. 13, 2013, 4 pages.
[cited by applicant]
Torigoe, H., et al., “Poly(L-lysine)-Graft-Dextran Copolymer Promotes Pyrimidine Motif Triplex DNA Formation At Physiological pH,” The Journal of Biological Chemistry, vol. 274, No. 10, pp. 6161-6167, Mar. 1999.
[cited by applicant]
Tosatti, S., et al., “Peptide functionalized poly(L-lysine)-g-poly(ethylene glycol) on titanium: resistance to protein adsorption in full heparinized human blood plasma,” Biomaterials, vol. 24, No. 27, pp. 4949-4958, De…
[cited by applicant]
Brazilian Office Action for Brazilian Patent Application No. PI1008602-1, dated Nov. 21, 2023, 12 pages.
[cited by applicant]
Nishiyama, N., et al., “Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery,” Pharmacology and Therapeutics, vol. 112, Issue 3, 2006, 630-648.
[cited by applicant]
Vandamme, T.F., “Microemulsions As Ocular Drug Delivery Systems: Recent Developments And Future Challenges,” Progress in Retinal and Eye Research, vol. 21, Issue 1, pp. 15-34, Jan. 2002.
[cited by applicant]
Vandevondele, S., et al., “RGD-Grafted Poly-L-Lysine-graft-(Polyethylene Glycol) Copolymers Block Non-Specific Protein Adsorption While Promoting Cell Adhesion,” Biotechnology and Bioengineering, vol. 82, No. 7, pp. 784…
[cited by applicant]
Wattendorf, U., et al., “Phagocytosis Of Poly(L-lysine)-graft-poly (ethylene glycol) Coated Microspheres By Antigen Presenting Cells: Impact Of Grafting Ratio And Poly (ethylene glycol) Chain Length On Cellular Recognit…
[cited by applicant]
Wilson, J., et al., “Noncovalent Cell Surface Engineering With Cationic Graft Copolymers,” Journal of the American Chemical Society, vol. 131, No. 51, pp. 18228-18229, Dec. 2009.
[cited by applicant]
Winblade, N., “Blocking Adhesion To Cell And Tissue Surfaces Via Steric Stabilization With Graft Copolymers Containing Poly(Ethylene Glycol) And Phenylboronic Acid,” Dissertation (Ph.D.), California Institute of Technol…
[cited by applicant]
Winblade, N., “Sterically Blocking Adhesion Of Cells To Biological Surfaces with a Surface-Active Copolymer Containing Poly(ethylene glycol) and Phenylboronic Acid,” Journal of Biomedical Materials Research , vol. 59, N…
[cited by applicant]
Winterton, L., et al., “The Elution Of Poly (Vinyl Alcohol) From A Contact Lens: The Realization Of A Time Release Moisturizing Agent/Artificial Tear,” Journal of Biomedical Materials Research, Part B, Applied Biomateri…
[cited by applicant]